Company intelligence / Profile preview
Tryp Therapeutics
Kelowna, British Columbia, Canadatryptherapeutics.com ↗
- Ownership
- Private
- Employees
- ~15
- Development stage
- Phase 2
01
Overview
Tryp has completed a Phase 2a trial in binge eating disorder showing >80% reduction in binge episodes. Interim results from the IBS trial show clinically meaningful decreases in abdominal pain and anxiety. The company’s approach uses oral synthetic psilocybin to demonstrate efficacy before advancing to their proprietary IV-infused psilocin formulation, which aims to improve onset time, control duration/depth of effect, and enhance patient experience.
- Therapeutic areas
- GastroenterologyPsychiatryRheumatologyOncologyNeurology
- Modalities
- Small molecule (psilocin and psilocybin)Synthetic small molecule
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
University of Florida – clinical trials for binge eating disorderUniversity of Michigan – clinical trials for fibromyalgiaMassachusetts General Hospital – clinical trials for IBSCollaborations with leading universities/research institutions globally
Beyond the preview
Go deeper on Tryp Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tryp Therapeutics.